Pomezia, Italy

Fiorella Petronzelli

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 2 CIPO patents and 2 EPO patents. Top assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.a.. Active years: 2012.

USPTO Granted Patents = 1 


 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Fiorella Petronzelli: Innovator in Antibody Development

Introduction

Fiorella Petronzelli is a notable inventor based in Pomezia, Italy. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic and diagnostic applications. Her work exemplifies the intersection of science and innovation.

Latest Patents

Fiorella Petronzelli holds a patent for an anti-EpCAM antibody, designated ST3232/10. This antibody, of marine origin, exhibits properties suitable for both therapeutic and diagnostic applications. It demonstrates high affinity for the native antigen and good tumor selectivity, making it a valuable asset in cancer treatment and diagnosis.

Career Highlights

Throughout her career, Petronzelli has worked with prominent companies in the pharmaceutical and research sectors. Notably, she has been associated with Sigma-Tau Industrie Farmaceutiche Riunite S.p.a. and Metheresis Translational Research S.a. Her expertise in antibody development has positioned her as a key figure in her field.

Collaborations

Fiorella has collaborated with esteemed colleagues, including Anna Maria Anastasi and Rita De Santis. These partnerships have furthered her research and contributed to advancements in antibody technology.

Conclusion

Fiorella Petronzelli's innovative work in the development of the anti-EpCAM antibody highlights her significant impact on biotechnology. Her contributions continue to pave the way for advancements in therapeutic and diagnostic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…